Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Retrospective Analysis of Hospital Medical Records on Medication and Supplement Use in Pregnant Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02842216
Recruitment Status : Completed
First Posted : July 22, 2016
Last Update Posted : August 22, 2017
Sponsor:
Collaborator:
Universitaire Ziekenhuizen Leuven
Information provided by (Responsible Party):
Michael Ceulemans, KU Leuven

Brief Summary:

Monocentric study in University Hospitals Leuven (campus Gasthuisberg).

Hospital medical records from all pregnant women who delivered between 01/07/2015 and 31/12/2015 in University Hospitals will be analyzed for the presence of medication and supplements.

Some demographic and obstetric parameters will be collected as well.

The anonymized dataset will be analyzed using descriptive statistics (Excel). There will be no intervention among the selected sample.


Condition or disease
Medication and Supplement Use During Pregnancy

Layout table for study information
Study Type : Observational
Actual Enrollment : 1200 participants
Observational Model: Case-Only
Time Perspective: Retrospective
Official Title: Retrospective Analysis of Hospital Medical Records on Medication and Supplement Use in Pregnant Women
Actual Study Start Date : July 2016
Actual Primary Completion Date : August 2017
Actual Study Completion Date : August 2017

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Number of registered medicines and supplements in hospital medical records of Belgian pregnant women [ Time Frame: Hospital medical records from 11 months before delivery until 1 month postpartum ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Pregnant women who delivered in the University Hospital of Leuven
Criteria

Inclusion Criteria:

  • All pregnant women who delivered in the University Hospital of Leuven between 01/07/2015 and 31/12/2015
Layout table for additonal information
Responsible Party: Michael Ceulemans, PhD Researcher, KU Leuven
ClinicalTrials.gov Identifier: NCT02842216    
Other Study ID Numbers: MC201601
First Posted: July 22, 2016    Key Record Dates
Last Update Posted: August 22, 2017
Last Verified: August 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Michael Ceulemans, KU Leuven:
Pharmaceutical preparations
Dietary supplements